Market Trends - The weight-loss drug market is expected to go truly global in 2026 due to the availability of cheap generic versions and new treatments in pill form [1]

Biocon plans to file for regulatory approvals of generic versions of Novo Nordisk A/S’s Ozempic and Wegovy in key markets https://t.co/4nfmYEbfo6 ...